Cooper Companies | COO - Stock


Cooper Companies reported $881M in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
AtriCure USD 78.49M 459K Dec/2025
Avanos Medical USD 148M 2.6M Dec/2025
Bausch Health Companies USD 1.6B 57M Sep/2025
Baxter International USD 2.23B 228M Dec/2025
Bayer EUR 12.33B 221M Sep/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Boston Scientific USD 2.94B 22M Dec/2025
Cooper Companies USD 881M 252.3M Jun/2025
Dentsply International USD 686M 11M Sep/2025
Dexcom USD 629.1M 25M Dec/2025
Edwards Lifesciences USD 1.14B 800K Sep/2025
Globus Medical USD 759.28M 12.26M Dec/2025
Haemonetics USD 321.18M 15.02M Dec/2025
Hologic USD 688.5M 9.1M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 452.6M 6.3M Dec/2025
Integra LifeSciences USD 492.73M 3.63M Dec/2025
Intuitive Surgical USD 1.84B 58.1M Dec/2025
J&J USD 14.19B 45M Dec/2025
Medtronic USD 6.16B 270M Sep/2025
Merit Medical Systems USD 333.7M 7.15M Dec/2025
Novartis USD 6.42B 114M Sep/2025
ResMed USD 922.04M 23.76M Dec/2025
STAAR Surgical USD 53.3M 195K Sep/2025
Steris USD 673.5M 15M Dec/2025
Stryker USD 5.31B 60M Dec/2025
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
Utah Medical Products 8.12M 115K Sep/2025
Zimmer Biomet Holdings USD 2.29B 197.3M Dec/2025